hepatitis b virus genotyping among chronic hepatitis b individuals with resistance to lamivudine in shahrekord, iran

نویسندگان

ali karimi medicinal plant research center, shahrekord university of medical sciences, shahrekord, ir iran

loghman salimzadeh medicinal plant research center, shahrekord university of medical sciences, shahrekord, ir iran; medicinal plant research center, shahrekord university of medical sciences, shahrekord, ir iran. tel:+98-3813334691, fax:+98-3813334911

nader bagheri department of immunology, school of public health, tehran university of medical sciences, tehran, ir iran

چکیده

methods and materials: hepatitis b virus dna was detected by conventional pcr in some of the serum samples obtained from hbsag-positive chronic hepatitis b (chb) patients who were referred to health centers of shahrekord for routine monitoring of the disease. subsequently, using real-time pcr, the dna samples were used for genotyping and analysis of resistance to lamivudine. results: the dna was detected in 23 out of 116 (19.82%) of the studied samples. genotypes d and c were found in 17 out of 23 (73.9%), and in 6 out of 23 (26.1%) of the samples, respectively. to the authors’ best knowledge, the current study is the first report on isolation of genotype c from iran. two out of 17 (11.76%), and 6 out of 6 (100%) of genotypes d and c were resistant to lamivudine, respectively. resistance to this drug was significantly different between genotypes c and d (p <0.001). objectives: the current study aimed to determine hepatitis b genotypes and their correlation with lamivudine- resistant hbv frequency among patients with chronic hepatitis b from shahrekord, iran. background: hepatitis b infection, caused by hepatitis b virus (hbv), is one of the major global public health problems. hepatitis b virus genotypes appear to show varying geographic distribution with possible pathogenic and therapeutic differences. knowledge of hbv genotypes is very important for clinical treatment. lamivudine is a nucleoside analogue that is clinically used to treat chronic hepatitis b infection. however, the main problem with the application of lamivudine is the development of viral resistance to the treatment with this anti viral drug. besides, it has been suggested that lamivudine -resistant hbv may be genotype dependent. however, hbv genotype distribution and the biological relevance in this region are poorly understood. conclusions: in addition to genotype d, other lamivudine resistant hepatitis b genotypes might be distributed in iran.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran

BACKGROUND Hepatitis B infection, caused by hepatitis B Virus (HBV), is one of the major global public health problems. Hepatitis B Virus genotypes appear to show varying geographic distribution with possible pathogenic and therapeutic differences. Knowledge of HBV genotypes is very important for clinical treatment. Lamivudine is a nucleoside analogue that is clinically used to treat chronic he...

متن کامل

The Absence of Hepatitis C Virus Infection Among Patients with Hepatitis B virus in Mashhad, Iran

Background and Aims: Many studies have provided evidence for the role of hepatitis B and C viruses in the development of liver cancer. Although the routine treatment is available for both conditions, no definite guideline is available to treat patients dually infected with HBV and HCV. This study was performed to determine the frequency of HBV/HCV-coinfection in Mashhad, North-East of Iran. Mat...

متن کامل

Mutations at Nucleotide 1762, 1764 and 1766 of Hepatitis B Virus X Gene in Patients with Chronic Hepatitis B and Hepatitis B-Related Cirrhosis

Abstract &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Background and objective: Hepatitis B virus (HBV) is a DNA virus with high tendency toward hepatic tissue. There are currently about 3 million HBV-infected people and 350 to 400 million chronic carriers of this virus in the world. X protein plays a role in the over-expression of oncogenes, carcinogenicity of liver cells and overlaps with the basal co...

متن کامل

Dynamics of hepatitis B virus resistance to lamivudine.

Lamivudine was the first approved inhibitor of hepatitis B virus (HBV) reverse transcriptase (RT). Lamivudine resistance develops in 53% to 76% of patients after 3 years of treatment. We extensively characterized the dynamics of HBV quasispecies variant populations in four HBV-infected patients who developed lamivudine resistance. Virological breakthrough was preceded by 2 to 4 months by the em...

متن کامل

CHARACTERISTICS AND PREVALENCE OF OCCULT HEPATITIS B VIRUS INFECTION IN PATIENTS WITH HEPATITIS C IN IRAN

 ABSTRACT Background: Hepatitis B virus (HBV) infection in patients who lack detectable hepatitis B surface antigen (HBsAg) is called occult hepatitis B infection. Such infections have been frequently identified in patients with chronic hepatitis Cliver disease, but their prevalence is not known. Methods: 207 patients with chronic hepatitis C who were HCV -RNA and antiHCV positive were stu...

متن کامل

Lamivudine resistance in untreated chronic hepatitis B patients in Turkey.

BACKGROUND/AIMS Hepatitis B virus infection is an epidemiological problem throughout the world, including in Turkey. Lamivudine is one of the hepatitis B virus reverse-transcriptase inhibitors used for the treatment of chronic hepatitis B virus infection. Lamivudine resistance can develop not only following treatment; it can also be seen in untreated patients. This resistance is related with st...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
jundishapur journal of microbiology

جلد ۷، شماره ۴، صفحات ۰-۰

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023